Latest Insider Transactions at Reata Pharmaceuticals Inc (RETA)
This section provides a real-time view of insider transactions for Reata Pharmaceuticals Inc (RETA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REATA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REATA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2020
|
William D. Mc Clellan Jr. Director |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$600,000
$150.01 P/Share
|
|
Nov 09
2020
|
William D. Mc Clellan Jr. Director |
BUY
Conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|
|
Nov 09
2020
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-25.77%
|
$4,375,000
$175.0 P/Share
|
|
Nov 18
2019
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
40,218
+18.1%
|
$7,359,894
$183.0 P/Share
|
|
Dec 12
2018
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
1,418
+0.5%
|
$83,662
$59.9 P/Share
|
|
Dec 11
2018
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
52,809
+32.55%
|
$3,168,540
$60.07 P/Share
|
|
Dec 10
2018
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
56,599
+29.32%
|
$3,282,742
$58.69 P/Share
|
|
Dec 29
2017
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
17,000
+27.78%
|
$476,000
$28.47 P/Share
|
|
Dec 28
2017
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
200
+0.73%
|
$5,200
$26.1 P/Share
|
|
Dec 27
2017
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
15,000
+35.71%
|
$375,000
$25.83 P/Share
|
|
Dec 26
2017
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
12,000
+50.0%
|
$312,000
$26.06 P/Share
|
|
Dec 14
2017
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
78,275
+4.82%
|
$1,878,600
$24.65 P/Share
|
|
Dec 13
2017
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
121,725
+3.87%
|
$2,921,400
$24.43 P/Share
|
|
Mar 28
2017
|
Abb Vie Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
450,000
-27.43%
|
$9,900,000
$22.5 P/Share
|
|
Feb 02
2017
|
Abb Vie Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,505,241
+47.85%
|
-
|